Human umbilical cord blood, an alternate source of haematopoietic stem cells (HSC),has been successfully used to reconstitute haematopoiesis in both related and unrelated transplant recipients. However, because CB has fewer total cells (and as a consequence fewer HSC and progenitor cells) CB transplant recipients often experience delayed engraftment as compared with that seen in bone marrow or mobilized peripheral blood transplant recipients. Delayed engraftment exposes patients to an increased risk of infection and bleeding. Cytokine-mediated expansion has been investigated to improve engraftment after CB HSC transplantation as a means to expand the total cell number and both the HSC and progenitors populations. However, its effect on HSC ...
Increasing demand for human hematopoietic stem cells (HSCs) in clinical and research applications ne...
The main limitations of hematopoietic cord blood (CB) transplantation, viz. low cell dosage and dela...
Expansion of haemopoietic stem cells is proposed to combat graft failure in adult recipients followi...
Cord blood (CB) is a source of hematopoietic stem cells (HSCs) and is an alternative to bone marrow ...
Since umbilical cord blood (UCB), contains a limited hematopoietic stem/progenitor cells (HSC) numbe...
textabstractThe goal of this thesis research is to establish ex vivo expansion conditions for HSCs d...
Umbilical cord blood (UCB) has been used for transplantation in the treatment of hematologic disorde...
Allogeneic transplantation with umbilical cord blood (UCB) is limited in adult recipients by a low C...
Short-term ex vivo expansion sustains the homing-related properties of umbilical cord blood hematopo...
Umbilical cord blood (UCB) is a well established alternative source of haematopoietic stem/progenito...
BACKGROUND: Cord blood (CB) is a promising source for hematopoietic stem cell transplantations. The ...
AbstractThe successful expansion of hematopoietic stem and progenitor cells (HSPCs) from umbilical c...
The insufficient number of haemopoietic stem cells (HSCs) In cord blood (CB) is the major potential ...
Motivation: Many important problems in cell biology require dense non-linear interactions between fu...
Umbilical cord blood transplantation is considered an alternative to traditional bone marrow transpl...
Increasing demand for human hematopoietic stem cells (HSCs) in clinical and research applications ne...
The main limitations of hematopoietic cord blood (CB) transplantation, viz. low cell dosage and dela...
Expansion of haemopoietic stem cells is proposed to combat graft failure in adult recipients followi...
Cord blood (CB) is a source of hematopoietic stem cells (HSCs) and is an alternative to bone marrow ...
Since umbilical cord blood (UCB), contains a limited hematopoietic stem/progenitor cells (HSC) numbe...
textabstractThe goal of this thesis research is to establish ex vivo expansion conditions for HSCs d...
Umbilical cord blood (UCB) has been used for transplantation in the treatment of hematologic disorde...
Allogeneic transplantation with umbilical cord blood (UCB) is limited in adult recipients by a low C...
Short-term ex vivo expansion sustains the homing-related properties of umbilical cord blood hematopo...
Umbilical cord blood (UCB) is a well established alternative source of haematopoietic stem/progenito...
BACKGROUND: Cord blood (CB) is a promising source for hematopoietic stem cell transplantations. The ...
AbstractThe successful expansion of hematopoietic stem and progenitor cells (HSPCs) from umbilical c...
The insufficient number of haemopoietic stem cells (HSCs) In cord blood (CB) is the major potential ...
Motivation: Many important problems in cell biology require dense non-linear interactions between fu...
Umbilical cord blood transplantation is considered an alternative to traditional bone marrow transpl...
Increasing demand for human hematopoietic stem cells (HSCs) in clinical and research applications ne...
The main limitations of hematopoietic cord blood (CB) transplantation, viz. low cell dosage and dela...
Expansion of haemopoietic stem cells is proposed to combat graft failure in adult recipients followi...